124 related articles for article (PubMed ID: 11411549)
41. Treatment of essential hypertension with calcium channel blockers: what is the place of lercanidipine?
Burnier M; Pruijm M; Wuerzner G
Expert Opin Drug Metab Toxicol; 2009 Aug; 5(8):981-7. PubMed ID: 19619074
[TBL] [Abstract][Full Text] [Related]
42. Comparison between the antiproteinuric effects of the calcium channel blockers benidipine and cilnidipine in combination with angiotensin receptor blockers in hypertensive patients with chronic kidney disease.
Abe M; Okada K; Maruyama N; Matsumoto S; Maruyama T; Fujita T; Matsumoto K; Soma M
Expert Opin Investig Drugs; 2010 Sep; 19(9):1027-37. PubMed ID: 20649501
[TBL] [Abstract][Full Text] [Related]
43. Side Effects of Frequently Used Antihypertensive Drugs on Wound Healing in vitro.
Stuermer EK; Besser M; Terberger N; Bachmann HS; Severing AL
Skin Pharmacol Physiol; 2019; 32(3):162-172. PubMed ID: 31018213
[TBL] [Abstract][Full Text] [Related]
44. Antihypertensive effects of long-acting calcium channel blockers on hemodialysis days--a randomized crossover trial between benidipine and nifedipine CR.
Kojima M; Taniguchi M; Sato K; Ueda R; Dohi Y
Nephron Clin Pract; 2004; 97(2):c49-53. PubMed ID: 15218330
[TBL] [Abstract][Full Text] [Related]
45. Comparison of efficacy and side effects of combination therapy of angiotensin-converting enzyme inhibitor (benazepril) with calcium antagonist (either nifedipine or amlodipine) versus high-dose calcium antagonist monotherapy for systemic hypertension.
Messerli FH; Oparil S; Feng Z
Am J Cardiol; 2000 Dec; 86(11):1182-7. PubMed ID: 11090788
[TBL] [Abstract][Full Text] [Related]
46. [Effects of angiotensin II receptor blockers, angiotensin converting enzyme inhibitors, 3-hydroxy-3-methyl glutaryl (HMG) CoA reductase inhibitors, amlodipine and epalrestat on cultured basilar artery smooth muscle cell proliferation].
Yamaguchi T; Ida T; Hiraga M; Oishi K; Uchida MK; Echizen H
Yakugaku Zasshi; 2004 Mar; 124(3):159-63. PubMed ID: 15049134
[TBL] [Abstract][Full Text] [Related]
47. Calcium channel blockers suppress cytokine-induced activation of human neutrophils.
Shima E; Katsube M; Kato T; Kitagawa M; Hato F; Hino M; Takahashi T; Fujita H; Kitagawa S
Am J Hypertens; 2008 Jan; 21(1):78-84. PubMed ID: 18091748
[TBL] [Abstract][Full Text] [Related]
48. Antihypertensive agents and renal protection: calcium channel blockers.
Saruta T; Kanno Y; Hayashi K; Konishi K
Kidney Int Suppl; 1996 Jun; 55():S52-6. PubMed ID: 8743511
[TBL] [Abstract][Full Text] [Related]
49. Cardiovascular effects of benidipine and amlodipine in isolated tissues and anesthetized dogs.
Moriyama T; Karasawa A
Biol Pharm Bull; 1994 Nov; 17(11):1468-71. PubMed ID: 7703965
[TBL] [Abstract][Full Text] [Related]
50. Beneficial effects of combination therapy with angiotensin II receptor blocker and angiotensin-converting enzyme inhibitor on vascular endothelial function.
Morimoto S; Maki K; Aota Y; Sakuma T; Iwasaka T
Hypertens Res; 2008 Aug; 31(8):1603-10. PubMed ID: 18971536
[TBL] [Abstract][Full Text] [Related]
51. Renoprotective effect of calcium channel blockers in combination with an angiotensin receptor blocker in elderly patients with hypertension. A randomized crossover trial between benidipine and amlodipine.
Miyagawa K; Dohi Y; Nakazawa A; Sugiura T; Yamashita S; Sato K; Kimura G
Clin Exp Hypertens; 2010 Jan; 32(1):1-7. PubMed ID: 20144066
[TBL] [Abstract][Full Text] [Related]
52. Modulation of the renin-angiotensin pathway through enzyme inhibition and specific receptor blockade in pacing-induced heart failure: II. Effects on myocyte contractile processes.
Spinale FG; Mukherjee R; Iannini JP; Whitebread S; Hebbar L; Clair MJ; Melton DM; Cox MH; Thomas PB; de Gasparo M
Circulation; 1997 Oct; 96(7):2397-406. PubMed ID: 9337216
[TBL] [Abstract][Full Text] [Related]
53. Calcium channel blockers as inhibitors of angiotensin I-converting enzyme.
Casarini DE; Carmona AK; Plavnik FL; Zanella MT; Juliano L; Ribeiro AB
Hypertension; 1995 Dec; 26(6 Pt 2):1145-8. PubMed ID: 7498985
[TBL] [Abstract][Full Text] [Related]
54. Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2.
Ferrario CM; Jessup J; Chappell MC; Averill DB; Brosnihan KB; Tallant EA; Diz DI; Gallagher PE
Circulation; 2005 May; 111(20):2605-10. PubMed ID: 15897343
[TBL] [Abstract][Full Text] [Related]
55. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
Palmieri V; Devereux RB
Minerva Cardioangiol; 2002 Jun; 50(3):169-74. PubMed ID: 12107398
[TBL] [Abstract][Full Text] [Related]
56. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial
JAMA; 2002 Dec; 288(23):2981-97. PubMed ID: 12479763
[TBL] [Abstract][Full Text] [Related]
57. The effects of lisinopril and nifedipine on parotid function: two case reports.
Streckfus CF; Welsh S; Jenkins P; Brown R; Miller V
MSDA J; 1992; 35(4):11-4. PubMed ID: 9552628
[No Abstract] [Full Text] [Related]
58. Angiotensin II type 1 receptor-mediated increase in cytosolic Ca(2+) and proliferation in mesothelial cells.
Kuwahara M; Miyaji T; Tsubone H
Eur J Pharmacol; 2000 Jan; 388(1):21-7. PubMed ID: 10657543
[TBL] [Abstract][Full Text] [Related]
59. Renal-protective effect of T-and L-type calcium channel blockers in hypertensive patients: an Amlodipine-to-Benidipine Changeover (ABC) study.
Ohishi M; Takagi T; Ito N; Terai M; Tatara Y; Hayashi N; Shiota A; Katsuya T; Rakugi H; Ogihara T
Hypertens Res; 2007 Sep; 30(9):797-806. PubMed ID: 18037772
[TBL] [Abstract][Full Text] [Related]
60. "Pulse" treatment with high-dose angiotensin blocker reverses renal arteriolar hypertrophy and regresses hypertension.
Ishiguro K; Hayashi K; Sasamura H; Sakamaki Y; Itoh H
Hypertension; 2009 Jan; 53(1):83-9. PubMed ID: 19047581
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
